Clinical Trials Logo

Larynx clinical trials

View clinical trials related to Larynx.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05746780 Completed - Larynx Cancer Clinical Trials

Bilateral Elective Neck Dissection in Salvage Total Laryngectomy

Start date: September 1, 2020
Phase:
Study type: Observational

The aim of this study is to evaluate the role of elective bilateral neck dissection in patients with clinically negative lymph nodes (cN0) who underwent salvage total laryngectomy, by estimating the prevalence of histologically positive occult lymph nodes (pN+). Secondary objective will be the assessment of complication rate and the evaluation of 5-year Overall Survival (OS) and 5-year Disease-Specific Survival (DSS) in these patients.

NCT ID: NCT03238365 Completed - Larynx Clinical Trials

Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck

Start date: August 10, 2017
Phase: Early Phase 1
Study type: Interventional

This randomized pilot early phase I trial studies how well nivolumab with or without tadalafil work in treating patients with head and neck squamous cell carcinoma that has come back and can be removed by surgery. Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread. Tadalafil may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving nivolumab and tadalafil may work better in treating patients head and neck squamous cell carcinoma.

NCT ID: NCT03162731 Completed - Larynx Clinical Trials

Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer

Start date: May 11, 2017
Phase: Early Phase 1
Study type: Interventional

This pilot clinical trial studies the side effects of nivolumab, ipilimumab and radiation therapy in treating patients with stage IVA-B head and neck cancer. Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving nivolumab, ipilimumab, and radiation therapy may work better in treating patients with stage IVA-B head and neck cancer.

NCT ID: NCT03109873 Completed - Larynx Clinical Trials

Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer

Start date: January 5, 2017
Phase: Early Phase 1
Study type: Interventional

This pilot clinical trial studies how well metformin hydrochloride works in affecting cytokines and exosomes in patients with head and neck cancer. Metformin hydrochloride may reduce the metabolic activity of cancer cells and of surrounding supportive tissues.

NCT ID: NCT03030781 Completed - Intubation Clinical Trials

Relationship of Cricoid With the Right and Left Bronchial Diameters in the Pediatric Population Using Three-dimensional Imaging.

Start date: August 2016
Phase: N/A
Study type: Observational

Specific and objective guidelines for choosing endobronchial tube size for main-stem intubation in pediatric patients are lacking. The objective criteria for choosing an ETT size for OLV are likely to increase the safety and success. The primary aims of this study were to define the relationship between cricoid and mainstem bronchi (right and left) in children of various ages and to determine the effects of age, height and weight.

NCT ID: NCT02761239 Completed - Larynx Clinical Trials

Innervation of Human Cricopharyngeal Muscle By Recurrent Laryngeal and External Branch of Superior Laryngeal Nerve

Start date: February 2015
Phase: N/A
Study type: Interventional

The investigators hypothesized that, external branch of the superior laryngeal nerve (EBSLN) and/or recurrent laryngeal nerve (RLN) contribute to the motor function of the human cricopharyngeal muscle (CP). The investigators aimed to assess the contribution of the laryngeal nerves (EBSLN and RLN) to the motor activity of the cricopharyngeal muscle, during thyroidectomy with intraoperative neuromonitoring (IONM).

NCT ID: NCT02126969 Completed - Clinical trials for Head and Neck Cancer

A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN

Start date: October 2014
Phase: Phase 2
Study type: Interventional

The primary hypothesis of this study is that hyper-radiosensitivity (HRS) seen at extremely low doses of radiation can be exploited to enhance the effect of chemotherapy, and that this effect differs from the cellular effect of higher, standard fractions of radiation used in traditional radiation treatment paradigms.

NCT ID: NCT01649973 Completed - Larynx Clinical Trials

Study for Appropriate Operating Table Height for Endotracheal Intubation Under Direct Laryngoscopy

Start date: March 2010
Phase: N/A
Study type: Observational

Laryngeal view of the patient and anesthesiologist's discomfort level during endotracheal intubation in relation to the various heights of operating table has not been investigated. The investigators hypothesis is higher table height will improve the laryngeal exposure.

NCT ID: NCT01321892 Completed - Clinical trials for Squamous Cell Carcinoma of the Oral Cavity

Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium

Start date: June 2009
Phase: N/A
Study type: Observational

The purpose of this research study is to collect information on whether images made using investigational microscopes can improve researchers' ability to evaluate and distinguish between normal and abnormal areas in tissue samples surgically removed from patients with squamous cell carcinoma. The microscopes being used in this study are considered investigational because they have not been approved by the United States Food and Drug Administration (FDA) for finding abnormal or pre-cancerous areas.

NCT ID: NCT01263873 Completed - Larynx Clinical Trials

Examining the Ease of Intubation Using the Parker Flex-Tip® or a Standard Endotracheal Tube

ETT
Start date: November 2010
Phase: N/A
Study type: Interventional

The purpose of the study is to determine if there are differences related to ease of intubation reported by clinicians who use the Parker Flex-Tip® endotracheal tubes(ETT)compared to the standard Mallinckrodt® (ETT). The problem is two (ETTs), the Parker Flex-Tip® and the Mallinckrodt®, are currently available for use in operative suites for intubation, but few studies have compared these devices with each other. Two research questions to be answered in the study are 1. Is there a difference in the ease of intubation when the Parker Flex-Tip® (ETT) is used when compared to the standard Mallinckrodt® (ETT)? and 2. Are there differences in the number of successful intubations when comparing the Parker Flex-Tip® (ETT) and the standard Mallinckrodt® (ETT)? The hypotheses are the use of the Parker Flex-Tip® (ETT) will demonstrate: 1. Fewer seconds to intubate the trachea. 2. Higher self-reported ease of placement scores and 3. Fewer redirections to intubate the trachea. The number of successful intubations is expected to be the same in both arms of the study.